1 / 44

Strategies Promoting Access to Medicines: The role of supply management

. . Strategies Promoting Access to Medicines: The role of supply management. Unit of Essential Medicines, Vaccines and Health Technologies, Nov 2004. Policy Development Process. Sep 2003: Governing bodies request PAHO to develop policy options for countries

heloise
Download Presentation

Strategies Promoting Access to Medicines: The role of supply management

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. . . Strategies Promoting Access to Medicines: The role of supply management Unit of Essential Medicines, Vaccines and Health Technologies, Nov 2004.

  2. Policy Development Process • Sep 2003: Governing bodies request PAHO to develop policy options for countries • March 2004: Strategic lines presented to the Sub-Committee of Planning and Programming • June 2004: Working Group (WHO, UNDP, MSH, MSF, countries and Collaborating Centers) develops strategic lines • June 2004: Executive Committee endorse policy options and drafts resolution • Sep 2004: Directing Council adopts policy options and resolution

  3. A Framework for Access Selection POLICY ACCESS REGULATION Financing Pricing RATIONAL USE QUALITY Supply Management

  4. Data on Pharmaceutical Expenditures (IMS) Data on Pharmaceutical Expenditures (IMS) 1994 1994 2001 2001 • Global Expenditure: • Global Expenditure: • US$ 364 billion • Latin America: • 5% or US$ 18.2 billion • Global Expenditure: • US$ 246 billion • Latin America: • 7% or US$ 18.5 billion • Lack of access to health care for large segments of the population • Increasing role of the public sector in health care provision • Intensification of cost containment in the pharmaceutical sector IMS DEC 2003

  5. Share of Household Health Expenditure by Type Source: Table A.6 (III) PAHO Health Accounts and National Health Accounts, 2003

  6. Strategic Lines for PAHO and Access WHO Medicines Strategy 2007 • Policy • Quality and Safety • Rational Use PAHO and • Coherent Generic Medicines Policy • Cost Containment Strategies • Commodity Supply Systems • Procurement Mechanisms Access

  7. 1. Developing Coherent Generic Policy • Understanding differences in definition • Reviewing legislation, regulations and policy • Examining incentives promoting generics: (production, registration, distribution, prescription, dispensing, and use) • Assessing impact • Providing Options

  8. 1. Developing Coherent Generic Policy

  9. 222% Armenia Brazil Ghana Kenya Peru Philippines S. Africa Sri Lanka (n=7) (n=8) (n=5) (n=10) (n=14) (n=9) (n=15) (n=10) Savings to Consumers and Governments from Buying Generic Brand median MPS Most sold generic median MPS 33% Generic savings 33% 108% 21% 423% 176% 186% 271% Source: WHO-HAI Medicine Prices, 2003

  10. Strategies to Achieve a Mature Generics Market National strategies for generics 1. Supportive legislation & regulation 2. Reliable quality assurance 3. Professional, public acceptance 4. Economic incentives Percent of new prescriptions, U.S.A. Source: WHO Rockefeller

  11. Strategic Lines for PAHO and Access WHO Medicines Strategy 2007 • Policy • Quality and Safety • Rational Use PAHO and • Coherent Generic Medicines Policy • Cost Containment Strategies • Commodity Supply Systems • Procurement Mechanisms Access

  12. 2. Cost Containment Approaches • Understanding Pricing • Tender Options • Negotiations • Price Controls • IP Regulatory Options provided for by TRIPS • Voluntary / Compulsory Licensing • Parallel Imports • Data Protection • Global, Regional and Bilateral Trade Agreements: Monitoring Access and Pricing

  13. Cost Containment for ARVs in Andean Countries Regional Price Negotiation for ARVs, REMSAA, June 2003, ORAS/PAHO

  14. 2. IP and Access • Meeting of the Working Group on IP (Nicaragua 2004) • Meeting of MOHs and Ministries of Trade and Commerce, Ecuador, Colombia and Peru, July 2004. • Methodologies to assess impact of trade agreements • Training materials for health professionals

  15. 2. Monitoring TRIPS Implementation in Latin America • Assessment in 11 countries, recently published in the Bulletin of the World Health Organization1 • Methodology: Analysis of IP legislation in 11 countries focusing on tersm of patents issued; patentable subject matter; transition periods; burden of proof of patent infringement; exhaustion rights, compulsory licensing; and early working. • Results: • By 2000 all countries had reformed legislation • 10 of 11 made use of TRIPS safeguards and flexibilities • Andean countries, DOR and Panama made use of parallel importing • Early working exception in two countries (DOR and Brazil) • Oliveira MA, Bermudez JAZ, Chaves GC, Velasquez G. • Bulletin of the World Health Organization. November 2004, 82 (11). Pp 815-820.

  16. Strategic Lines for PAHO and Access WHO Medicines Strategy 2007 • Policy • Quality and Safety • Rational Use PAHO and • Coherent Generic Medicines Policy • Cost Containment Strategies • Commodity Supply Systems • Procurement Mechanisms Access

  17. 3. Access and Supply Management • To ensure continuous availability of essential medicines and public health supplies • of quality • coherent with the needs of the public health system • focusing on priority public health programs • maximizing resource utilization • using efficient and dynamic administrative and management processes • promoting rational use of pharmaceutical products

  18. An Overview of the System

  19. Characteristics of a Supply Management System • Pharmaceutical Management Framework • Product Selection • Acquisition • Inventory Management and Distribution • Rational Use • Monitoring and Evaluation

  20. The Pharmaceutical Supply Management Framework A:National / Regional Pharmaceutical Policy

  21. 1. The Pharmaceutical Supply Management Framework B:Definition of the Supply System • MOH / Drug Regulatory Authority • MOH / Dept. Pharmacy Services • MOH / Procurement Service • MOH / Priority Programs • Ministry of Finance • Central Medical Stores • Social Security System • Therapeutic Committees • Drug Selection Committees • Tendering Committees • Reference Hospitals • Primary Health Care Pharmacies • Community Pharmacies • National QC Laboratories • MOH / Pharmaco-surveillance Rational Use Acquisition

  22. 1. The Pharmaceutical Supply Management Framework B:Definition of the Supply System • .Definition of Responsibilities • Identification of Coordination • Mechanisms • Integration of Existing Institutions • & Programs Rational Use Acquisition

  23. Operational Framework for Supply Management: COHAN, Colombia Coordination MOH Technology Transfer Research Supply System Training Selection & Needs Estimation Quantitative Approaches Qualitative Purchases Technical Support Marketing Stock Managememnt Sales Rational Use Source: COHAN 2004

  24. Product Selection • National Therapeutic and Drug Selection Committees based on information provided in • Treatment Norms • National Essential Drug List • Cost v Therapeutic Class

  25. Product Selection Financial Regulations And Admin. Procedures Health Regulations And Drug Registration • Requires understanding • of the • Public Health • Regulatory Framework Commercial and IP Regulations

  26. Product Acquisition • Good Practices for Pharmaceutical Procurement, WHO 2002: presents basic principles for effective pharmaceutical procurement • Selection of reliable manufacturers and suppliers (Prequalification) • Lowest cost for products of quality • Appropriate delivery times • Transparent procurement procedures and management

  27. Product Acquisition Compilation of Information Financial Quantity Market Intelligence Reference Prices Morbidity Data Treatment Norms Local / International Availability Historic Use Procedures Funding Patent Original/Brand INCOTERMS Taxes

  28. Inventory Management & Distribution… means Information Management By: product, batch no, expiry date, budget line, health program, location etc Customs, Taxes, Registration, Quality & Order verification, Costing Product, Presentation, Qt Suppliers, Prequalification Pricing, Shipping, Delivery Times Institution information, Product picking, Invoicing & Accounting, Shipping & Transport, Usage Evaluation

  29. Rational Use & Drug Supply Systems Monitoring Rational Use Adherence to Treatment Norms Registering Product Use Monitoring Clinical Response Surveillance for Adverse Reactions & Resistance Changes in Product In the Supply Chain Product Availability & Affordability

  30. Monitoring an Evaluation • Pharmaceutical Management Framework • Product Selection • Acquisition • Inventory Management and Distribution • Rational Use Process Indicators + Result Indicators

  31. The HR Factor

  32. PAHO Program of Work 2004 Supply Management • Regional Workshops in HIV/AIDS to Assess the Gaps • Caribbean (February 2004) & Central America (August 2004) • Methodology: • Participation of HIV/AIDS Program Managers, HR Managers, Chief Pharmaceutical Officers, Strategic Planning Managers Country Reports • WG1: Assessment of Minimum Requirements for scaling up by country, focusing on Logistics, HR and Planning • WG2: Assessment of Min. Requirements, inter-country by area • WG3: Definition of priorities by country and TC requirements

  33. Results of Workshop / Caribbean Total 5,417 6,656 1,239

  34. TC Priorities for Caribbean • Processes of quantification, prequalification and procurement • IPR and Drug Regulation • Coordination Mechanisms in Supply Management • Training in Procurement and Supply Management (using WB materials) • Direct support to countries and CARICOM on IP and drug regulation assessment and options • Development of regional capacity in QC • Establishment of Caribbean Network of Procurement and Supply Management Agencies (CariPRO)

  35. Results of Workshop / Central America

  36. Priority Areas in Pharmaceutical Supply Management Identified by Central American Countries M&E Information / Communication Pharmaco.Vigil Rational Use GDP/GSP Distribution Planning Acquisition Management Procurement Regulation Knowledge of Reg. Frame. Selection Def. Responsibilities Coordination mechanisms Nacional Policy 0 10 20 30 40 50 60 70 80 % Priority by element Results of Workshop / Central America

  37. TC Priorities for Central America • Monitoring and Evaluation: Performance Assessment of the Supply Chain • Good Storage and Distribution Practices • Coordination Mechanisms in Supply Management • Support in performance assessment • Good Storage and Distribution Practices • Networking / Intercountry cooperation • Assessments of Supply System in NIC and HON

  38. Strategic Lines for PAHO and Access WHO Medicines Strategy 2007 • Policy • Quality and Safety • Rational Use PAHO and • Coherent Generic Medicines Policy • Cost Containment Strategies • Commodity Supply Systems • Procurement Mechanisms Access

  39. 4. Procurement / PAHO Strategic Fund 2000 2004 • Established by the Director, with formal invitations to countries • A procurement mechanism to support countries in supply management of prequalified TB, HIV, and malaria public health supplies • 12 Countries with signed participation agreements • >US$ 14 million in purchase orders by three countries • Strategic review of Fund framework through SPP and PAHO Working Group

  40. The Review Process – WHO Audit • Procurement Funds and Linkages to Technical Cooperation in the Americas, March - April 2004 • To assess the efficiency of the process and the effectiveness of activities in the achievement of stated objectives. • Methodology: reviewing planning, program design and implementation, reliability of information, communication and monitoring

  41. Recommendations from the Audit • The Strategic Fund should be a fundamental component of the PAHO strategy to promote Access to priority public health supplies • Political impetus be provided through advocacy to Member States • The product mix be reviewed • Technical cooperation scope and mechanisms be developed specifically in demand forecasting, supply management and quality at the country level.

  42. Strategic Fund Work Program 2005 • Focus on PAHO/AMRO priority countries and the Caribbean • Update technical framework document and product mix • Review of legal framework to facilitate participation of GFTAM projects • Commence training in focus countries

  43. And Finally…. We´ve lots to do…. !!!! And we can do it together Thank You - Gracias

  44. Next Steps • Modify TORs, prepare meeting report and disseminate • Modify Indicators and disseminate. Set date for collection • Establish the Sharepoint website • Organize next meeting (April 04 with PAHO/WB training?)

More Related